CoV-2 N (196 a.a.)

Product Name CoV-2 N (196 a.a.)

Product Number SARS-042

Synonym(s) Coronavirus 2019 Nucleocapsid (196 a.a.), Recombinant


A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019.

The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans.

While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

Description The E. coli derived recombinant protein contains the Coronavirus 2019 middle region  a.a. from the nucleocapsid protein and fused to GST-6xHis tag at N-terminal and having a M.W. Of 48.4 kDa.

Source E. coli

Purification Method PNTA Sepharose-Affinity Purification

Formulation CoV-2 Nucleocapsid protein solution is supplied in 50mM Tris-HCl pH 8, 1M Urea, and 50% Glycerol.

Stability CoV-2 Spike Protein is shipped on ice packs. Upon arrival, Store at -20°C.

Physical Appearance Sterile filtered clear solution.

CoV-2 Nucleocapsid protein is >95% pure as determined SDS-PAGE.

Storage Conditions -20ºC

Delivery Details 7-10 days

Special Note(s) For research use ONLY. Not for use on humans.

Document(s) SDS